HOME >> MEDICINE >> NEWS
NIH convenes panel to assess evidence on chronic insomnia

The National Institutes of Health (NIH) will hold a State-of-the-Science Conference on the Manifestations and Management of Chronic Insomnia in Adults on June 13-15, 2005, at the Natcher Conference Center, on the NIH campus in Bethesda, MD. A press briefing will be held at the close of the conference, at 2:00 p.m. on Wednesday, June 15.

During the first day and part of the second day of the conference, experts will present the latest findings in the research of chronic insomnia to an independent panel. The panel will then meet in executive session to weigh the available scientific evidence and prepare its statement assessing the state of the science, to be presented for public comment at 9:00 a.m. on Wednesday, June 15.

Insomnia is the most common sleep complaint reported by women and men across all stages of adulthood and for many, the problem is chronic. While insomnia often exists simultaneously with other medical conditions (co-morbidities), the definitive etiology (cause) of insomnia remains unknown. Nevertheless, chronic insomnia is associated with a wide range of adverse consequences (morbidities), including depression, alcohol and drug abuse, difficulties with concentration and memory, and various cardiovascular, pulmonary, and gastrointestinal disorders. In addition to reduced quality of life and increased health care use reported by insomnia sufferers, the large number of people experiencing insomnia ultimately results in significant economic burden to society in lost productivity and health care costs. Although a number of promising behavioral and pharmacological approaches have recently been identified for the management of chronic insomnia symptoms, there has been limited guidance for clinicians in terms of choice of treatment.

The panel's statement will address these five key questions:

  • How is chronic insomnia defined, diagnosed, and classified, and what is known about its etiology?
  • What are the prevalenc
    '"/>


Contact: OMAR Information Center
nihcdp@mail.nih.gov
888-644-2667
NIH/Office of the Director
3-Jun-2005


Page: 1 2 3

Related medicine news :

1. American College of Physicians Foundation convenes conference
2. New Orleans levee report finished by panel including University of Texas at Austin engineer
3. IOF and EU panel prepare osteoporosis audit
4. RAND panel identifies key components of public health emergency preparedness
5. Medical, IT, engineering experts form advisory panel for electronic health record safety
6. SCAI expert panel sets high standards for PCI without on-site cardiac surgical backup
7. Conference on health communication call for papers and panel proposals
8. Consensus panel calls for expanded role of needle biopsies, MRI and less invasive procedures
9. Independent panel to evaluate a chemical used in some plastics for hazards to human health
10. Children need 60 minutes of daily physical activity, expert panel says
11. Children need 60 minutes of daily physical activity, expert panel says

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NIH convenes panel assess evidence chronic insomnia

(Date:4/26/2015)... New York, New York (PRWEB) April 26, 2015 ... convened on April 21, 2015 in the U.S. ... of federally-filed testosterone lawsuits ( http://www.testosteronelawsuithub.com/ ) ... pretrial proceedings. According to court documents, matters addressed ... to seek dismissal of claims involving their products ...
(Date:4/26/2015)... (PRWEB) April 26, 2015 Italian public ... deadly legacy of asbestos cement plants and other asbestos-related ... the new research. Click here to read it ... Italy’s Department of Occupational and Environmental Medicine analyzed more ... and found 32 clusters where the asbestos cancer was ...
(Date:4/26/2015)... 26, 2015 Compare-autoinsurance.org has released a new ... quotes . , The easiest way to find low cost ... access to the best offers online, in a simple and ... providers for information about auto insurance prices. All the details ... page. , It is now possible to compare online ...
(Date:4/26/2015)... (PRWEB) April 26, 2015 Indiana Fiber ... provider announces that Brotherhood Mutual Insurance Company has selected ... Manager of Network Infrastructure at Brotherhood Mutual Insurance Company ... the service reliability Brotherhood Mutual needed. We ... and IFN worked with us to ensure we achieved ...
(Date:4/26/2015)... With the FCPX LUT B&W pack from ... can quickly and easily add desaturated color grades to footage. ... formula for modifying an image. The LUT changes every pixel's ... pack comes with 60 black and white CUBE LUT files. ... and white films. With the FCPX LUT B&W Loader ...
Breaking Medicine News(10 mins):Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 3Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 4Health News:New Investigation Finds Mesothelioma “Clusters” Around Italian Cement Plants, According to Surviving Mesothelioma 2Health News:Finding Low Cost Auto Insurance - An Online Guide Provides Tips 2Health News:Brotherhood Mutual Insurance Company Selects Indiana Fiber Network, LLC for Fiber Transport Service 2Health News:Brotherhood Mutual Insurance Company Selects Indiana Fiber Network, LLC for Fiber Transport Service 3Health News:Pixel Film Studios, a FCPX Effects Developer, Announced the Release of FCPX LUT B&W 2
(Date:4/23/2015)... , April 24, 2015  AbbVie (NYSE: ... Drug Administration (FDA) has accepted its New Drug Application ... interferon-free, two direct-acting antiviral treatment of ombitasvir, paritaprevir, ritonavir ... treatment of adults with chronic genotype 4 (GT4) hepatitis ... the first all-oral, interferon-free therapy being evaluated by the ...
(Date:4/23/2015)...  ResMed Inc. (NYSE: RMD ) today announced ... for the quarter was $422.5 million, a 6 percent ... (a 13 percent increase on a constant currency basis).  ... percent compared to the quarter ended March 31, 2014.  ... an increase of 2 percent compared to the quarter ...
(Date:4/23/2015)... 2015 /CNW/ - Health Canada is working with the ... the safety information regarding the risk of serious cardiovascular ... products are used at high doses (at or above ... of use. Ibuprofen is a non-steroidal anti-inflammatory ... to reduce inflammation. The majority of ibuprofen products in ...
Breaking Medicine Technology:U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 11ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 12ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 13Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 2Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 3Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 4
Cached News: